Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction - PubMed (original) (raw)
Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction
A Billiau et al. Eur J Immunol. 1987 Dec.
Abstract
A generalized Shwartzman reaction was found to occur in non-SPF-NMRI mice given a local injection of S. marcescens lipopolysaccharide (LPS) in the footpad, followed, with an interval of 24 h, by an i.v. injection. The reaction occurred several hours after the second injection. It was characterized by disseminated subcutaneous bleedings at the mouth, anus, conjuctiva, nose tip and tail end. Most mice died within 24-48 h. The size of the LPS dose given in the footpad (5 micrograms) was found to be critical in that the reaction failed to occur with higher as well as lower doses. The reaction was found to be completely absent in mice that had received one or more systemic injections of monoclonal antibodies with neutralizing potential for murine interferon-gamma (IFN-gamma). Mice treated with control preparations, including a monoclonal antibody with binding but no neutralizing activity for murine IFN-gamma, remained sensitive to induction of the reaction. These observations assign a crucial role to endogenous IFN-gamma in the elicitation of the generalized Shwartzman reaction and open perspectives for the prevention or therapy of clinical conditions related to the Shwartzman reaction by the use of antibodies to IFN-gamma.
Similar articles
- Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice.
Heremans H, Dillen C, van Damme J, Billiau A. Heremans H, et al. Eur J Immunol. 1994 May;24(5):1155-60. doi: 10.1002/eji.1830240522. Eur J Immunol. 1994. PMID: 8181525 - Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice.
Heremans H, Van Damme J, Dillen C, Dijkmans R, Billiau A. Heremans H, et al. J Exp Med. 1990 Jun 1;171(6):1853-69. doi: 10.1084/jem.171.6.1853. J Exp Med. 1990. PMID: 2112583 Free PMC article. - Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide.
Heremans H, Dijkmans R, Sobis H, Vandekerckhove F, Billiau A. Heremans H, et al. J Immunol. 1987 Jun 15;138(12):4175-9. J Immunol. 1987. PMID: 2438336 - Clinical potential of monoclonal antibodies against gamma interferon.
Heremans H, De Baetselier P, Billiau A. Heremans H, et al. Dev Biol Stand. 1990;71:113-9. Dev Biol Stand. 1990. PMID: 2119318 Review. - The role of cytokines in various animal models of inflammation.
Heremans H, Dillen C, Dijkmans R, Grau G, Billiau A. Heremans H, et al. Lymphokine Res. 1989 Fall;8(3):329-33. Lymphokine Res. 1989. PMID: 2506397 Review.
Cited by
- Inhibition of IL-12 heterodimers impairs TLR9-mediated prevention of early mouse plasmacytoma cell growth.
Mandour MF, Soe PP, Castonguay AS, Van Snick J, Coutelier JP. Mandour MF, et al. Front Med (Lausanne). 2023 Jan 13;9:1057252. doi: 10.3389/fmed.2022.1057252. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36714124 Free PMC article. - Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma development.
Mandour MF, Soe PP, Uyttenhove C, Van Snick J, Marbaix E, Coutelier JP. Mandour MF, et al. Infect Agent Cancer. 2020 May 7;15:30. doi: 10.1186/s13027-020-00288-6. eCollection 2020. Infect Agent Cancer. 2020. PMID: 32391074 Free PMC article. - Immune therapy in sepsis: Are we ready to try again?
Davies R, O'Dea K, Gordon A. Davies R, et al. J Intensive Care Soc. 2018 Nov;19(4):326-344. doi: 10.1177/1751143718765407. Epub 2018 Apr 4. J Intensive Care Soc. 2018. PMID: 30515242 Free PMC article. Review. - Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.
Jackson SS, Schmitz JE, Letvin NL. Jackson SS, et al. Clin Vaccine Immunol. 2011 Nov;18(11):1969-78. doi: 10.1128/CVI.05180-11. Epub 2011 Sep 7. Clin Vaccine Immunol. 2011. PMID: 21900534 Free PMC article. - Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection.
Uyttenhove C, Marillier RG, Tacchini-Cottier F, Charmoy M, Caspi RR, Damsker JM, Goriely S, Su D, Van Damme J, Struyf S, Opdenakker G, Van Snick J. Uyttenhove C, et al. J Leukoc Biol. 2011 Jun;89(6):1001-7. doi: 10.1189/jlb.1210699. Epub 2011 Mar 8. J Leukoc Biol. 2011. PMID: 21385949 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources